CareTrust REIT, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
CTRE$38.84-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| For the Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income | $133,095 | $39,168 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization (including below-market ground leases) | 39,122 | 27,337 |
| Amortization of deferred financing costs | 1,898 | 1,228 |
| Unrealized (gain) loss on other real estate related investments, net | (3,255) | 2,489 |
| Amortization of stock-based compensation | 6,935 | 3,526 |
| Straight-line rental income | (1,753) | 14 |
| Amortization of lease incentives | 97 | 4 |
| Amortization of above and below market leases | (1,899) | (1,150) |
| Noncash interest income | (1,581) | (1,813) |
| Gain on sale of real estate, net | (3,876) | (32) |
| Impairment of real estate investments | — | 28,455 |
| Change in operating assets and liabilities: | ||
| Accounts and other receivables | 573 | (719) |
| Prepaid expenses and other assets, net | (459) | (983) |
| Accounts payable, accrued liabilities and deferred rent liabilities | 3,260 | 4,271 |
| Net cash provided by operating activities | 172,157 | 101,795 |
| Cash flows from investing activities: | ||
| Acquisitions of real estate, net of deposits applied | (820,046) | (204,554) |
| Purchases of equipment, furniture and fixtures and improvements to real estate | (6,783) | (1,323) |
| Preferred equity investments | (30,000) | (9,000) |
| Investment in real estate related investments and other loans receivable | (21,715) | (244,825) |
| Principal payments received on real estate related investments and other loans receivable | 9,857 | — |
| Escrow deposits for potential acquisitions of real estate | (1,020) | (9,075) |
| Net proceeds from sales of real estate | 44,401 | 140 |
| Net cash used in investing activities | (825,306) | (468,637) |
| Cash flows from financing activities: | ||
| Proceeds from the issuance of common stock, net | 365,282 | 572,236 |
| Proceeds from the issuance of senior unsecured term loan | 500,000 | — |
| Proceeds from the secured borrowing | — | 75,000 |
| Borrowings under unsecured revolving credit facility | 525,000 | — |
| Payments on unsecured revolving credit facility | (525,000) | — |
| Payments of deferred financing costs | (4,189) | (24) |
| Net-settle adjustment on restricted stock | (3,325) | (2,483) |
| Dividends paid on common stock | (117,440) | (77,723) |
| Contributions from noncontrolling interests | 6,888 | 576 |
| Distributions to noncontrolling interests | (2,157) | (54) |
| Net cash provided by financing activities | 745,059 | 567,528 |
| Effect of foreign currency translation on cash and cash equivalents | 319 | — |
| Net increase in cash and cash equivalents | 92,229 | 200,686 |
| Cash and cash equivalents as of the beginning of period | 213,822 | 294,448 |
| Cash and cash equivalents as of the end of period | $306,051 | $495,134 |
| Supplemental disclosures of cash flow information: | ||
| Interest paid | $16,392 | $15,289 |
| Supplemental schedule of noncash investing and financing activities: | ||
| Increase in dividends payable | $12,713 | $8,190 |
| Right-of-use asset obtained in exchange for new operating lease obligation | $1,465 | $— |
| Transfer of pre-acquisition costs to acquired assets | $— | $58 |
| Sale of real estate settled with note receivable | $— | $1,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.